The VERSANT ® kPCR Molecular System for PCR testing offers true molecular testing versatility. The VERSANT kPCR Molecular System provides precise and trustworthy outcomes with utmost flexibility ...

The company, which raised $84 million, sees validation of its GIP-blocking approach to weight loss in Amgen's recent MariTide ...

Antag Therapeutics thinks its glucose dependent insulinotropic polypeptide receptor (GIPR) antagonist could carve out a space ...

Round led by Versant Ventures with participation from founding investor Novo Holdings and new investors SR One, Dawn Biopharma and Pictet-- --Entering Phase I testing for next-generation weight loss ...